Originally posted here. Executive summary Patient and user safety with regards to medical devices is paramount. This should be prioritised in situations where there are competing considerations such as “attractiveness of the UK” as to the conduct of clinical trials and supply of medicines and medical devices. The existing regulatory framework for medicines and medical … Continue reading “Briefing note: Medicines and Medical Devices Bill (July update)”
